Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
July-2020 Volume 44 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2020 Volume 44 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells

  • Authors:
    • Soteroula Thrasyvoulou
    • Georgios Vartholomatos
    • Georgios Markopoulos
    • Dimitrios Noutsopoulos
    • Stefania Mantziou
    • Foteini Gkartziou
    • Panagiotis Papageorgis
    • Antonia Charchanti
    • Panos Kouklis
    • Andreas I. Constantinou
    • Theodore Tzavaras
  • View Affiliations / Copyright

    Affiliations: Laboratory of General Biology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece, Laboratory of Hematology, Unit of Molecular Biology, University Hospital of Ioannina, 45110 Ioannina, Greece, Biological Sciences Program, Department of Life Sciences, School of Sciences, European University Cyprus, 2404 Nicosia, Cyprus, Laboratory of Anatomy‑Histology‑Embryology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece, Department of Biological Sciences, Faculty of Pure and Applied Sciences, University of Cyprus, 1678 Nicosia, Cyprus
  • Pages: 126-138
    |
    Published online on: April 28, 2020
       https://doi.org/10.3892/or.2020.7596
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Retrotransposons copy their sequences via an RNA intermediate, followed by reverse transcription into cDNA and random insertion, into a new genomic locus. New retrotransposon copies may lead to cell transformation and/or tumorigenesis through insertional mutagenesis. Methylation is a major defense mechanism against retrotransposon RNA expression and retrotransposition in differentiated cells, whereas stem cells are relatively hypo‑methylated. Epithelial‑to‑mesenchymal transition (EMT), which transforms normal epithelial cells into mesenchymal‑like cells, also contributes to tumor progression and tumor metastasis. Cancer stem cells (CSCs), a fraction of undifferentiated tumor‑initiating cancer cells, are reciprocally related to EMT. In the present study, the outcome of long terminal repeat (LTR)‑Viral‑Like 30 (VL30) retrotransposition was examined in mouse mammary stem‑like/progenitor HC11 epithelial cells. The transfection of HC11 cells with a VL30 retrotransposon, engineered with an EGFP‑based retrotransposition cassette, elicited a higher retrotransposition frequency in comparison to differentiated J3B1A and C127 mouse mammary cells. Fluorescence microscopy and PCR analysis confirmed the specificity of retrotransposition events. The differentiated retrotransposition‑positive cells retained their epithelial morphology, while the respective HC11 cells acquired mesenchymal features associated with the loss of E‑cadherin, the induction of N‑cadherin, and fibronectin and vimentin protein expression, as well as an increased transforming growth factor (TGF)‑β1, Slug, Snail‑1 and Twist mRNA expression. In addition, they were characterized by cell proliferation in low serum, and the acquisition of CSC‑like properties indicated by mammosphere formation under anchorage‑independent conditions. Mammospheres exhibited an increased Nanog and Oct4 mRNA expression and a CD44+/CD24‑/low antigenic phenotype, as well as self‑renewal and differentiation capacity, forming mammary acini‑like structures. DNA sequencing analysis of retrotransposition‑positive HC11 cells revealed retrotransposed VL30 copies integrated at the vicinity of EMT‑, cancer type‑ and breast cancer‑related genes. The inoculation of these cells into Balb/c mice produced cytokeratin‑positive tumors containing pancytokeratin‑positive cells, indicative of cell invasion features. On the whole, the findings of the present study demonstrate, for the first time, to the best of our knowledge, that stem‑like epithelial HC11 cells are amenable to VL30 retrotransposition associated with the induction of EMT and CSC generation, leading to tumorigenesis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Markopoulos G, Noutsopoulos D, Mantziou S, Gerogiannis D, Thrasyvoulou S, Vartholomatos G, Kolettas E and Tzavaras T: Genomic analysis of mouse VL30 retrotransposons. Mob DNA. 7:102016. View Article : Google Scholar : PubMed/NCBI

2 

French NS and Norton JD: Structure and functional properties of mouse VL30 retrotransposons. Biochim Biophys Acta. 1352:33–47. 1997. View Article : Google Scholar : PubMed/NCBI

3 

Noutsopoulos D, Markopoulos G, Koliou M, Dova L, Vartholomatos G, Kolettas E and Tzavaras T: Vanadium induces VL30 retrotransposition at an unusually high level: A possible carcinogenesis mechanism. J Mol Biol. 374:80–90. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Tzavaras T, Eftaxia S, Tavoulari S, Hatzi P and Angelidis C: Factors influencing the expression of endogenous reverse transcriptases and viral-like 30 elements in mouse NIH3T3 cells. Int J Oncol. 23:1237–1243. 2003.PubMed/NCBI

5 

Tzavaras T, Kalogera C, Eftaxia S, Saragosti S and Pagoulatos GN: Clone-specific high-frequency retrotransposition of a recombinant virus containing a VL30 promoter in SV40-transformed NIH3T3 cells. Biochim Biophys Acta. 1442:186–198. 1998. View Article : Google Scholar : PubMed/NCBI

6 

Song X, Sun Y and Garen A: Roles of PSF protein and VL30 RNA in reversible gene regulation. Proc Natl Acad Sci USA. 102:12189–12193. 2005. View Article : Google Scholar : PubMed/NCBI

7 

Wang G, Cui Y, Zhang G, Garen A and Song X: Regulation of proto-oncogene transcription, cell proliferation, and tumorigenesis in mice by PSF protein and a VL30 noncoding RNA. Proc Natl Acad Sci USA. 106:16794–16798. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Song X, Sui A and Garen A: Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: Effects on steroidogenesis and oncogenesis. Proc Natl Acad Sci USA. 101:621–626. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Costain WJ, Rasquinha I, Graber T, Luebbert C, Preston E, Slinn J, Xie X and MacManus JP: Cerebral ischemia induces neuronal expression of novel VL30 mouse retrotransposons bound to polyribosomes. Brain Res. 1094:24–37. 2006. View Article : Google Scholar : PubMed/NCBI

10 

Scolnick EM, Vass WC, Howk RS and Duesberg PH: Defective retrovirus-like 30S RNA species of rat and mouse cells are infectious if packaged by type C helper virus. J Virol. 29:964–972. 1979. View Article : Google Scholar : PubMed/NCBI

11 

Song X, Wang B, Bromberg M, Hu Z, Konigsberg W and Garen A: Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an immunodeficient mouse model. Proc Natl Acad Sci USA. 99:6269–6273. 2002. View Article : Google Scholar : PubMed/NCBI

12 

Noutsopoulos D, Vartholomatos G, Kolaitis N and Tzavaras T: SV40 large T antigen up-regulates the retrotransposition frequency of viral-like 30 elements. J Mol Biol. 361:450–461. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Noutsopoulos D, Markopoulos G, Vartholomatos G, Kolettas E, Kolaitis N and Tzavaras T: VL30 retrotransposition signals activation of a caspase-independent and p53-dependent death pathway associated with mitochondrial and lysosomal damage. Cell Res. 20:553–562. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Boeke JD, Garfinkel DJ, Styles CA and Fink GR: Ty elements transpose through an RNA intermediate. Cell. 40:491–500. 1985. View Article : Google Scholar : PubMed/NCBI

15 

Georgiou I, Noutsopoulos D, Dimitriadou E, Markopoulos G, Apergi A, Lazaros L, Vaxevanoglou T, Pantos K, Syrrou M and Tzavaras T: Retrotransposon RNA expression and evidence for retrotransposition events in human oocytes. Hum Mol Genet. 18:1221–1228. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Goodier JL and Kazazian HH Jr: Retrotransposons revisited: The restraint and rehabilitation of parasites. Cell. 135:23–35. 2008. View Article : Google Scholar : PubMed/NCBI

17 

Guarino M, Rubino B and Ballabio G: The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI

18 

Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED and Thompson EW: Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol. 213:374–383. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Papageorgis P, Lambert AW, Ozturk S, Gao F, Pan H, Manne U, Alekseyev YO, Thiagalingam A, Abdolmaleky HM, Lenburg M and Thiagalingam S: Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res. 70:968–978. 2010. View Article : Google Scholar : PubMed/NCBI

20 

Barrallo-Gimeno A and Nieto MA: The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development. 132:3151–3161. 2005. View Article : Google Scholar : PubMed/NCBI

21 

Bhowmick NA, Neilson EG and Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature. 432:332–337. 2004. View Article : Google Scholar : PubMed/NCBI

22 

Moreno-Bueno G, Portillo F and Cano A: Transcriptional regulation of cell polarity in EMT and cancer. Oncogene. 27:6958–6969. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Hayashida T, Jinno H, Kitagawa Y and Kitajima M: Cooperation of cancer stem cell properties and epithelial-mesenchymal transition in the establishment of breast cancer metastasis. J Oncol. 2011:5914272011. View Article : Google Scholar : PubMed/NCBI

24 

Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI

25 

Daniel CW, Young LJ, Medina D and DeOme KB: The influence of mammogenic hormones on serially transplanted mouse mammary gland. Exp Gerontol. 6:95–101. 1971. View Article : Google Scholar : PubMed/NCBI

26 

Smith GH and Medina D: Re-evaluation of mammary stem cell biology based on in vivo transplantation. Breast Cancer Res. 10:2032008. View Article : Google Scholar : PubMed/NCBI

27 

Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J, Sharma N, Dekoninck S and Blanpain C: Distinct stem cells contribute to mammary gland development and maintenance. Nature. 479:189–193. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Holland JD, Klaus A, Garratt AN and Birchmeier W: Wnt signaling in stem and cancer stem cells. Curr Opin Cell Biol. 25:254–264. 2013. View Article : Google Scholar : PubMed/NCBI

29 

Zhou W, Wang G and Guo S: Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells. Biochim Biophys Acta. 1836:304–320. 2013.PubMed/NCBI

30 

Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI

31 

Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI

32 

Goodier JL: Restricting retrotransposons: A review. Mob DNA. 7:162016. View Article : Google Scholar : PubMed/NCBI

33 

Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE and Jaenisch R: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 448:318–324. 2007. View Article : Google Scholar : PubMed/NCBI

34 

Ball RK, Friis RR, Schoenenberger CA, Doppler W and Groner B: Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J. 7:2089–2095. 1988. View Article : Google Scholar : PubMed/NCBI

35 

Humphreys RC and Rosen JM: Stably transfected HC11 cells provide an in vitro and in vivo model system for studying Wnt gene function. Cell Growth Differ. 8:839–849. 1997.PubMed/NCBI

36 

Williams C, Helguero L, Edvardsson K, Haldosen LA and Gustafsson JA: Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression. Breast Cancer Res. 11:R262009. View Article : Google Scholar : PubMed/NCBI

37 

Montesano R, Soriano JV, Fialka I and Orci L: Isolation of EpH4 mammary epithelial cell subpopulations which differ in their morphogenetic properties. In Vitro Cell Dev Biol Anim. 34:468–477. 1998. View Article : Google Scholar : PubMed/NCBI

38 

Ostertag EM, Prak ET, DeBerardinis RJ, Moran JV and Kazazian HH Jr: Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res. 28:1418–1423. 2000. View Article : Google Scholar : PubMed/NCBI

39 

Puschendorf M, Stein P, Oakeley EJ, Schultz RM, Peters AH and Svoboda P: Abundant transcripts from retrotransposons are unstable in fully grown mouse oocytes. Biochem Biophys Res Commun. 347:36–43. 2006. View Article : Google Scholar : PubMed/NCBI

40 

Xiong Y and Eickbush TH: Origin and evolution of retroelements based upon their reverse transcriptase sequences. EMBO J. 9:3353–3362. 1990. View Article : Google Scholar : PubMed/NCBI

41 

Langmead B and Salzberg SL: Fast gapped-read alignment with Bowtie 2. Nat Methods. 9:357–359. 2012. View Article : Google Scholar : PubMed/NCBI

42 

M M: Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17:10–12. 2011. View Article : Google Scholar

43 

Voulgari A and Pintzas A: Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta. 1796:75–90. 2009.PubMed/NCBI

44 

Jen J and Wang YC: Zinc finger proteins in cancer progression. J Biomed Sci. 23:532016. View Article : Google Scholar : PubMed/NCBI

45 

Davis NM, Sokolosky M, Stadelman K, Abrams SL, Libra M, Candido S, Nicoletti F, Polesel J, Maestro R, D'Assoro A, et al: Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: Possibilities for therapeutic intervention. Oncotarget. 5:4603–4650. 2014. View Article : Google Scholar : PubMed/NCBI

46 

Li X, Yang Q, Yu H, Wu L, Zhao Y, Zhang C, Yue X, Liu Z, Wu H, Haffty BG, et al: LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway. Oncotarget. 5:788–801. 2014. View Article : Google Scholar : PubMed/NCBI

47 

Barak V, Goike H, Panaretakis KW and Einarsson R: Clinical utility of cytokeratins as tumor markers. Clin Biochem. 37:529–540. 2004. View Article : Google Scholar : PubMed/NCBI

48 

Merlo GR, Venesio T, Taverna D, Marte BM, Callahan R and Hynes NE: Growth suppression of normal mammary epithelial cells by wild-type p53. Oncogene. 9:443–453. 1994.PubMed/NCBI

49 

Hancks DC and Kazazian HH Jr: Active human retrotransposons: Variation and disease. Curr Opin Genet Dev. 22:191–203. 2012. View Article : Google Scholar : PubMed/NCBI

50 

Yoder JA, Walsh CP and Bestor TH: Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13:335–340. 1997. View Article : Google Scholar : PubMed/NCBI

51 

Konisti S, Mantziou S, Markopoulos G, Thrasyvoulou S, Vartholomatos G, Sainis I, Kolettas E, Noutsopoulos D and Tzavaras T: H2O2 signals via iron induction of VL30 retrotransposition correlated with cytotoxicity. Free Radic Biol Med. 52:2072–2081. 2012. View Article : Google Scholar : PubMed/NCBI

52 

Markopoulos G, Noutsopoulos D, Mantziou S, Vartholomatos G, Monokrousos N, Angelidis C and Tzavaras T: Arsenic induces VL30 retrotransposition: The involvement of oxidative stress and heat-shock protein 70. Toxicol Sci. 134:312–322. 2013. View Article : Google Scholar : PubMed/NCBI

53 

Deugnier MA, Faraldo MM, Teuliere J, Thiery JP, Medina D and Glukhova MA: Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. Dev Biol. 293:414–425. 2006. View Article : Google Scholar : PubMed/NCBI

54 

Bloushtain-Qimron N, Yao J, Snyder EL, Shipitsin M, Campbell LL, Mani SA, Hu M, Chen H, Ustyansky V, Antosiewicz JE, et al: Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci USA. 105:14076–14081. 2008. View Article : Google Scholar : PubMed/NCBI

55 

Heidmann T, Heidmann O and Nicolas JF: An indicator gene to demonstrate intracellular transposition of defective retroviruses. Proc Natl Acad Sci USA. 85:2219–2223. 1988. View Article : Google Scholar : PubMed/NCBI

56 

Maston GA, Evans SK and Green MR: Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet. 7:29–59. 2006. View Article : Google Scholar : PubMed/NCBI

57 

Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nature reviews. Mol Cell Biol. 15:178–196. 2014.

58 

Vesuna F, van Diest P, Chen JH and Raman V: Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun. 367:235–241. 2008. View Article : Google Scholar : PubMed/NCBI

59 

Moustakas A and Heldin P: TGFβ and matrix-regulated epithelial to mesenchymal transition. Biochim Biophys Acta. 1840:2621–2634. 2014. View Article : Google Scholar : PubMed/NCBI

60 

Adissu HA, Asem EK and Lelievre SA: Three-dimensional cell culture to model epithelia in the female reproductive system. Reprod Sci. 14:11–19. 2007. View Article : Google Scholar : PubMed/NCBI

61 

Tantin D: Oct transcription factors in development and stem cells: insights and mechanisms. Development. 140:2857–2866. 2013. View Article : Google Scholar : PubMed/NCBI

62 

Fuxe J, Vincent T and Garcia de Herreros A: Transcriptional crosstalk between TGF-beta and stem cell pathways in tumor cell invasion: Role of EMT promoting Smad complexes. Cell Cycle. 9:2363–2374. 2010. View Article : Google Scholar : PubMed/NCBI

63 

Duensing S and Munger K: Centrosomes, genomic instability, and cervical carcinogenesis. Crit Rev Eukaryot Gene Expr. 13:9–23. 2003. View Article : Google Scholar : PubMed/NCBI

64 

Ponti D, Zaffaroni N, Capelli C and Daidone MG: Breast cancer stem cells: An overview. Eur J Cancer. 42:1219–1224. 2006. View Article : Google Scholar : PubMed/NCBI

65 

Stingl J and Caldas C: Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer. 7:791–799. 2007. View Article : Google Scholar : PubMed/NCBI

66 

Nishi M, Sakai Y, Akutsu H, Nagashima Y, Quinn G, Masui S, Kimura H, Perrem K, Umezawa A, Yamamoto N, et al: Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors. Oncogene. 33:643–652. 2014. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Thrasyvoulou S, Vartholomatos G, Markopoulos G, Noutsopoulos D, Mantziou S, Gkartziou F, Papageorgis P, Charchanti A, Kouklis P, Constantinou AI, Constantinou AI, et al: VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells. Oncol Rep 44: 126-138, 2020.
APA
Thrasyvoulou, S., Vartholomatos, G., Markopoulos, G., Noutsopoulos, D., Mantziou, S., Gkartziou, F. ... Tzavaras, T. (2020). VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells. Oncology Reports, 44, 126-138. https://doi.org/10.3892/or.2020.7596
MLA
Thrasyvoulou, S., Vartholomatos, G., Markopoulos, G., Noutsopoulos, D., Mantziou, S., Gkartziou, F., Papageorgis, P., Charchanti, A., Kouklis, P., Constantinou, A. I., Tzavaras, T."VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells". Oncology Reports 44.1 (2020): 126-138.
Chicago
Thrasyvoulou, S., Vartholomatos, G., Markopoulos, G., Noutsopoulos, D., Mantziou, S., Gkartziou, F., Papageorgis, P., Charchanti, A., Kouklis, P., Constantinou, A. I., Tzavaras, T."VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells". Oncology Reports 44, no. 1 (2020): 126-138. https://doi.org/10.3892/or.2020.7596
Copy and paste a formatted citation
x
Spandidos Publications style
Thrasyvoulou S, Vartholomatos G, Markopoulos G, Noutsopoulos D, Mantziou S, Gkartziou F, Papageorgis P, Charchanti A, Kouklis P, Constantinou AI, Constantinou AI, et al: VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells. Oncol Rep 44: 126-138, 2020.
APA
Thrasyvoulou, S., Vartholomatos, G., Markopoulos, G., Noutsopoulos, D., Mantziou, S., Gkartziou, F. ... Tzavaras, T. (2020). VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells. Oncology Reports, 44, 126-138. https://doi.org/10.3892/or.2020.7596
MLA
Thrasyvoulou, S., Vartholomatos, G., Markopoulos, G., Noutsopoulos, D., Mantziou, S., Gkartziou, F., Papageorgis, P., Charchanti, A., Kouklis, P., Constantinou, A. I., Tzavaras, T."VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells". Oncology Reports 44.1 (2020): 126-138.
Chicago
Thrasyvoulou, S., Vartholomatos, G., Markopoulos, G., Noutsopoulos, D., Mantziou, S., Gkartziou, F., Papageorgis, P., Charchanti, A., Kouklis, P., Constantinou, A. I., Tzavaras, T."VL30 retrotransposition is associated with induced EMT, CSC generation and tumorigenesis in HC11 mouse mammary stem‑like epithelial cells". Oncology Reports 44, no. 1 (2020): 126-138. https://doi.org/10.3892/or.2020.7596
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team